211 related articles for article (PubMed ID: 22545969)
1. Evaluation of cisplatin in combination with β-elemene as a regimen for prostate cancer chemotherapy.
Li QQ; Wang G; Reed E; Huang L; Cuff CF
Basic Clin Pharmacol Toxicol; 2010 Nov; 107(5):868-76. PubMed ID: 22545969
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of cisplatin-induced apoptosis by β-elemene in resistant human ovarian cancer cells.
Li QQ; Lee RX; Liang H; Zhong Y; Reed E
Med Oncol; 2013 Mar; 30(1):424. PubMed ID: 23277286
[TBL] [Abstract][Full Text] [Related]
3. β-Elemene promotes cisplatin-induced cell death in human bladder cancer and other carcinomas.
Li QQ; Wang G; Liang H; Li JM; Huang F; Agarwal PK; Zhong Y; Reed E
Anticancer Res; 2013 Apr; 33(4):1421-8. PubMed ID: 23564782
[TBL] [Abstract][Full Text] [Related]
4. beta-Elemene, a novel plant-derived antineoplastic agent, increases cisplatin chemosensitivity of lung tumor cells by triggering apoptosis.
Li QQ; Wang G; Zhang M; Cuff CF; Huang L; Reed E
Oncol Rep; 2009 Jul; 22(1):161-70. PubMed ID: 19513519
[TBL] [Abstract][Full Text] [Related]
5. β-elemene effectively suppresses the growth and survival of both platinum-sensitive and -resistant ovarian tumor cells.
Lee RX; Li QQ; Reed E
Anticancer Res; 2012 Aug; 32(8):3103-13. PubMed ID: 22843880
[TBL] [Abstract][Full Text] [Related]
6. Synergistic Cytotoxicity of β-Elemene and Cisplatin in Gingival Squamous Cell Carcinoma by Inhibition of STAT3 Signaling Pathway.
Huang C; Yu Y
Med Sci Monit; 2017 Mar; 23():1507-1513. PubMed ID: 28355175
[TBL] [Abstract][Full Text] [Related]
7. Antineoplastic effect of beta-elemene on prostate cancer cells and other types of solid tumour cells.
Li QQ; Wang G; Huang F; Banda M; Reed E
J Pharm Pharmacol; 2010 Aug; 62(8):1018-27. PubMed ID: 20663036
[TBL] [Abstract][Full Text] [Related]
8. In vitro combination characterization of the new anticancer plant drug beta-elemene with taxanes against human lung carcinoma.
Zhao J; Li QQ; Zou B; Wang G; Li X; Kim JE; Cuff CF; Huang L; Reed E; Gardner K
Int J Oncol; 2007 Aug; 31(2):241-52. PubMed ID: 17611679
[TBL] [Abstract][Full Text] [Related]
9. β-Elemene enhances susceptibility to cisplatin in resistant ovarian carcinoma cells via downregulation of ERCC-1 and XIAP and inactivation of JNK.
Li QQ; Lee RX; Liang H; Wang G; Li JM; Zhong Y; Reed E
Int J Oncol; 2013 Sep; 43(3):721-8. PubMed ID: 23817665
[TBL] [Abstract][Full Text] [Related]
10. β-elemene induces caspase-dependent apoptosis in human glioma cells in vitro through the upregulation of Bax and Fas/ FasL and downregulation of Bcl-2.
Li CL; Chang L; Guo L; Zhao D; Liu HB; Wang QS; Zhang P; Du WZ; Liu X; Zhang HT; Liu Y; Zhang Y; Xie JH; Ming JG; Cui YQ; Sun Y; Zhang ZR; Jiang CL
Asian Pac J Cancer Prev; 2014; 15(23):10407-12. PubMed ID: 25556484
[TBL] [Abstract][Full Text] [Related]
11. Antiproliferative effect of beta-elemene in chemoresistant ovarian carcinoma cells is mediated through arrest of the cell cycle at the G2-M phase.
Li X; Wang G; Zhao J; Ding H; Cunningham C; Chen F; Flynn DC; Reed E; Li QQ
Cell Mol Life Sci; 2005 Apr; 62(7-8):894-904. PubMed ID: 15868412
[TBL] [Abstract][Full Text] [Related]
12. β-elemene reverses the drug resistance of lung cancer A549/DDP cells via the mitochondrial apoptosis pathway.
Yao CC; Tu YR; Jiang J; Ye SF; Du HX; Zhang Y
Oncol Rep; 2014 May; 31(5):2131-8. PubMed ID: 24627125
[TBL] [Abstract][Full Text] [Related]
13. β-Elemene and taxanes synergistically induce cytotoxicity and inhibit proliferation in ovarian cancer and other tumor cells.
Zou B; Li QQ; Zhao J; Li JM; Cuff CF; Reed E
Anticancer Res; 2013 Mar; 33(3):929-40. PubMed ID: 23482764
[TBL] [Abstract][Full Text] [Related]
14. The p53 upregulated modulator of apoptosis (PUMA) chemosensitizes intrinsically resistant ovarian cancer cells to cisplatin by lowering the threshold set by Bcl-x(L) and Mcl-1.
Yuan Z; Cao K; Lin C; Li L; Liu HY; Zhao XY; Liu L; Deng HX; Li J; Nie CL; Wei YQ
Mol Med; 2011; 17(11-12):1262-74. PubMed ID: 21863213
[TBL] [Abstract][Full Text] [Related]
15. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species.
Yang YI; Kim JH; Lee KT; Choi JH
Gynecol Oncol; 2011 Dec; 123(3):588-96. PubMed ID: 21945308
[TBL] [Abstract][Full Text] [Related]
16. Novel combination therapy against metastatic and androgen-independent prostate cancer by using gefitinib, tamoxifen and etoposide.
Mimeault M; Venkatraman G; Johansson SL; Moore E; Henichart JP; Depreux P; Lin MF; Batra SK
Int J Cancer; 2007 Jan; 120(1):160-9. PubMed ID: 17013895
[TBL] [Abstract][Full Text] [Related]
17. Anticancer activity of β-Elemene and its synthetic analogs in human malignant brain tumor cells.
Li QQ; Lee RX; Liang H; Zhong Y
Anticancer Res; 2013 Jan; 33(1):65-76. PubMed ID: 23267129
[TBL] [Abstract][Full Text] [Related]
18. Treatment with β-elemene combined with paclitaxel inhibits growth, migration, and invasion and induces apoptosis of ovarian cancer cells by activation of STAT-NF-κB pathway.
Xiaomeng F; Lei L; Jinghong A; Juan J; Qi Y; Dandan Y
Braz J Med Biol Res; 2020; 53(6):e8885. PubMed ID: 32401925
[TBL] [Abstract][Full Text] [Related]
19. Sensitization of lung cancer cells to cisplatin by β-elemene is mediated through blockade of cell cycle progression: antitumor efficacies of β-elemene and its synthetic analogs.
Li QQ; Wang G; Huang F; Li JM; Cuff CF; Reed E
Med Oncol; 2013 Mar; 30(1):488. PubMed ID: 23397083
[TBL] [Abstract][Full Text] [Related]
20. β-Elemene against human lung cancer via up-regulation of P53 protein expression to promote the release of exosome.
Li J; JunYu ; Liu A; Wang Y
Lung Cancer; 2014 Nov; 86(2):144-50. PubMed ID: 25204604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
